Cardiovascular Considerations in COVID19: A Comprehensive Review
Faeze Keihanian,1,2 Leila Bigdelu1,3 1Cardiovascular Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; 2Pharmaceutical Research Center, Booali Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; 3Vascular and Endovascular Surgery Research Cen...
Guardado en:
Autores principales: | Keihanian F, Bigdelu L |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/216285a124b144beb5f41e036631ceff |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
N-Acetylcysteine to Combat COVID-19: An Evidence Review
por: Shi Z, et al.
Publicado: (2020) -
An Up-to-Date Overview of Therapeutic Agents for the Treatment of COVID-19 Disease
por: Mulaw Belete T
Publicado: (2020) -
Hypercytokinemia and Pathogen–Host Interaction in COVID-19
por: Badawi A
Publicado: (2020) -
Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
por: Masoumeh Farahani, et al.
Publicado: (2022) -
Doxycycline in the Coronavirus Disease 2019 Therapy
por: Dorobisz K, et al.
Publicado: (2021)